• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·ALKYLAMINE.NS
Share

Alkyl Amines Chemicals Limited Stocks

₹ 1844.7Last Updated 16.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 993.54M

₹ 1844.7
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include aliphatic amines such as methylamines, ethylamines, and isopropylamines, alongside numerous amine derivatives like dimethylamine hydrochloride and 3-ethoxy propylamine. Additionally, it provides unique chemical compounds, including acetonitrile and 2-aminoethoxy ethanol. Its clientele spans multiple industries, prominently including the pharmaceutical, agrochemical, water treatment, and rubber chemical sectors. Established in 1979, the company's main office is situated in Navi Mumbai, India.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of ALKYLAMINE.NS is 1804 and suggests 2.23% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommenda

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 22:51

Plata, a fintech company founded by former Tinkoff employees, has reached $1 billion in annual revenue

19.10.2026 22:31

Morgan Stanley expects Amazon's stock to rise by 40%. What do AI agents have to do with this?

19.10.2026 21:53

Apple Has Announced the Date of the Event Where It Will Unveil the First Touchscreen MacBook — Bloomberg

19.10.2026 21:49

"Davos in the Desert" has been postponed due to attacks. Fink and Solomon were scheduled to speak there.

19.10.2026 21:11

"Not all Neoclouds are the same": Experts recommend buying CoreWeave and Nebius after the market correction

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026